Mtl Centrum Medyczne Pulawska Sp. z o.o. S.K.
- Address
- Aleja Rzeczypospolitej 1, 02-972 Warsaw, Poland
MTL Centrum Medyczne Puławska - Pediatric Infectious Disease Research
MTL Centrum Medyczne Puławska is a clinical research facility specializing in pediatric infectious disease prevention and vaccine development. The center focuses on protecting vulnerable infant populations through participation in innovative preventive medicine trials targeting respiratory syncytial virus (RSV) and other serious pediatric respiratory infections.
- Respiratory syncytial virus (RSV) prevention in healthy infants
- Safety and efficacy evaluation of pediatric immunoprophylaxis interventions
- Medically attended lower respiratory infection (MALRI) prevention studies
The research center conducts comprehensive safety and tolerability assessments of investigational preventive therapies, with expertise in monitoring adverse events and evaluating clinical endpoints in the infant population. Their work contributes to the development of protective interventions that aim to reduce the burden of respiratory infections during the critical early months of life.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Mtl Centrum Medyczne Pulawska Sp. z o.o. S.K.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants | Merck Sharp & Dohme LLC | Phase IV | Not Recruiting | Nov 2022 | Feb 2024 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.